293 related articles for article (PubMed ID: 19574900)
1. Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression.
Iovieno A; Lambiase A; Moretti C; Perrella E; Bonini S
Cornea; 2009 Aug; 28(7):821-4. PubMed ID: 19574900
[TBL] [Abstract][Full Text] [Related]
2. Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma.
Määttä M; Santala M; Soini Y; Turpeenniemi-Hujanen T; Talvensaari-Mattila A
Acta Obstet Gynecol Scand; 2010 Mar; 89(3):380-4. PubMed ID: 20109015
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
Unsal Kilic D; Uner A; Akyurek N; Erpolat P; Dursun A; Pak Y
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):196-203. PubMed ID: 17071013
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival intraepithelial neoplasia.
Snyder ME
Ophthalmology; 2003 Jul; 110(7):1289. PubMed ID: 12867379
[No Abstract] [Full Text] [Related]
6. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
Chen YS; Langhammer T; Westhofen M; Lorenzen J
Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
[TBL] [Abstract][Full Text] [Related]
7. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia.
Ng J; Coroneo MT; Wakefield D; Di Girolamo N
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5295-306. PubMed ID: 18641285
[TBL] [Abstract][Full Text] [Related]
9. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil.
Midena E; Angeli CD; Valenti M; de Belvis V; Boccato P
Br J Ophthalmol; 2000 Mar; 84(3):268-72. PubMed ID: 10684836
[TBL] [Abstract][Full Text] [Related]
10. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.
Mannello F; Jung K; Tonti GA; Canestrari F
Clin Biochem; 2008 Dec; 41(18):1466-73. PubMed ID: 18926810
[TBL] [Abstract][Full Text] [Related]
11. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves.
Togashi M; Tamura K; Nitta T; Ishizaki M; Sugisaki Y; Fukuda Y
Pathol Int; 2007 May; 57(5):251-9. PubMed ID: 17493172
[TBL] [Abstract][Full Text] [Related]
12. [Expression of matrix metalloproteinase-2, -9 and their inhibitor-1 in hypertrophic scars].
Xie XF; He LX; Hao XF; Chen B; Jia CY; Sun ZG; Cao YJ; Li DH
Zhonghua Shao Shang Za Zhi; 2007 Dec; 23(6):444-6. PubMed ID: 18457258
[TBL] [Abstract][Full Text] [Related]
13. Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface.
Honda N; Miyai T; Nejima R; Miyata K; Mimura T; Usui T; Aihara M; Araie M; Amano S
Arch Ophthalmol; 2010 Apr; 128(4):466-71. PubMed ID: 20385943
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine.
Eissa S; Ali-Labib R; Swellam M; Bassiony M; Tash F; El-Zayat TM
Eur Urol; 2007 Nov; 52(5):1388-96. PubMed ID: 17466450
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients.
Zdzisińska B; Walter-Croneck A; Kandefer-Szerszeń M
Leuk Res; 2008 Nov; 32(11):1763-9. PubMed ID: 18472160
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat.
Pham Van T; Couchie D; Martin-Garcia N; Laperche Y; Zafrani ES; Mavier P
Matrix Biol; 2008 Oct; 27(8):674-81. PubMed ID: 18678246
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of MMP (TIMP)-1 in conjunctival melanomas and clinical implications.
Kim HK; Chae SW; Woo KI; Kim YD
Jpn J Ophthalmol; 2010 May; 54(3):221-6. PubMed ID: 20577856
[TBL] [Abstract][Full Text] [Related]
19. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
20. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma.
Wiegand S; Dünne AA; Müller HH; Mandic R; Barth P; Davis RK; Werner JA
Cancer; 2005 Jul; 104(1):94-100. PubMed ID: 15912516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
